Home > Insider Trading > Filing (0001289340-12-000093)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1289340	Stereotaxis Inc.	STXS	Electromedical & Electrotherapeutic Apparatus (3845)	943120386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1267959	A Fred Middleton	400 South El Camino Real Suite 1200 San Mateo CA 94402-1708		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-11-30	24,360	$1.53	76,072	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	782,272	Indirect	Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock	28,117	Indirect	Sanderling Ventures Management VI
Common Stock	3,060	Indirect	Sanderling VI Beteiligungs GmbH & Co. KG
Common Stock	3,647	Indirect	Sanderling VI Limited Partnership
Common Stock	1,500	Indirect	Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan
Common Stock	53,275	Indirect	Sanderling IV Biomedical Co-Investment Fund, L.P.
Common Stock	11,097	Indirect	Sanderling V Beteiligungs GmbH & Co. KG
Common Stock	39,716	Indirect	Sanderling V Biomedical Co-Investment Fund, L.P.
Common Stock	11,956	Indirect	Sanderling V Limited Partnership
Common Stock	67,790	Indirect	Sanderling Venture Partners V Co-Investment Fund, L.P.
Common Stock	22,451	Indirect	Sanderling Venture Partners IV Co-Investment Fund
Common Stock	82	Indirect	Sanderling Ventures Management V
Common Stock	79	Indirect	Middleton McNeil Retirement Trust

Footnotes

Purchase of 24,360 shares of Stereotaxis, Inc. common stock from the limited partners of Sanderling Venture Partners II, LP in connection with the liquidation of the partnership. In previous reports, the reporting person reported indirect beneficial ownership in 78,135 shares of Stereotaxis, Inc. common stock held by Sanderling Venture Partners II, LP.
Includes pro-rata liquidating disribution of 6,148 shares from Sanderling Venture Partners, II LP. In previous reports, the reporting person reported indirect beneficial ownership in 78,135 shares of Stereotaxis, Inc. common stock held by Sanderling Venture Partners II, LP.